Status:
COMPLETED
Prophylactic Ivermectin in COVID-19 Contacts
Lead Sponsor:
Zagazig University
Conditions:
COVID
Eligibility:
All Genders
16-70 years
Phase:
PHASE2
PHASE3
Brief Summary
asymptomatic family close contact of confirmed COVID -19 patient will receive prophylactic ivermectin and will be followed up for 14 days for any symptoms \& diagnosis of COVID -19
Eligibility Criteria
Inclusion
- family contact of confirmed COVID-19 case
Exclusion
- refuse to participate and receive the drug pregnancy or lactation known hypersensitivity to ivermectin
Key Trial Info
Start Date :
May 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 27 2020
Estimated Enrollment :
340 Patients enrolled
Trial Details
Trial ID
NCT04422561
Start Date
May 31 2020
End Date
July 27 2020
Last Update
August 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig University
Zagazig, Sharqia Province, Egypt, 44519